Tag Archives: Diabetes

Dr Will Johnson of Loughborough University: the concept of ‘healthy obesity’ is inherently flawed

Leicestershire, UK, 17-Apr-2018 — /EuropaWire/ — The on-going debate over whether ‘health obesity’ exists is diverting attention away from effective medical research as academics continue to use the confusing classification. The concept – which relates to people with high BMI but … Read the full press release

Diabetes: US FDA approval for Medtronic’s Guardian(TM) Connect continuous glucose monitoring (CGM) system

 ‘Smart’ CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received … Read the full press release

Medtronic at the Advanced Technologies & Treatments for Diabetes (ATTD) 11th International Conference in Vienna, Austria, February 14-17

Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA, 14-Feb-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the Advanced Technologies & Treatments for … Read the full press release

University of Exeter’s Professor Andrew Hattersley earns CBE for his work in diabetes research

EXETER, 09-Feb-2018 — /EuropaWire/ — A world-leading diabetes expert today (Thursday 8th February) received his CBE for his work in revolutionising global diagnosis and treatment. Andrew Hattersley, Professor of Molecular Medicine at the University of Exeter and a diabetes consultant at the Royal Devon … Read the full press release

University of Dundee: Smoking and diabetes are leading risk factors for peripheral artery disease (PAD)

research also points to diabetes as cause of disease that can lead to limb amputation DUNDEE, 20-Sep-2017 — /EuropaWire/ — Smoking and diabetes are the two leading risk factors for peripheral artery disease (PAD), a narrowing of the arteries which can … Read the full press release

Medtronic presented results of iPro2 Professional CGM at 9th International Conference on Advanced Technologies & Treatments for Diabetes

iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy MILAN, 08-Feb-2016 — /EuropaWire/ — A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, … Read the full press release

University of Aberdeen: UK and US scientists made major step forward in understanding how the brain senses low glucose levels

For people suffering from diabetes, managing blood sugar can be like walking a tightrope – if too high they run the risk of serious long term complications such as blindness, kidney failure, limb gangrene and premature heart disease, but allow … Read the full press release

University of Leicester led team published new findings about the link between low blood glucose and cardiovascular events

International team led by University of Leicester publish new findings Leicester, UK, 15-12-2014 — /EuropaWire/ — A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in … Read the full press release

Sanofi and Medtronic partner to improve patient experience and outcomes for people with diabetes around the world

Initial focus on insulin-device combinations and care management services Paris and Minneapolis, Minn., 16-6-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to enter into a … Read the full press release

HumEn project received €6M EU grant to develop stem cell-based treatment of diabetes

STEM CELLS A grant of 6 million euros for the HumEn project brings together leading European stem cell-research groups and industrial partners in a coordinated and collaborative effort aimed at developing glucose-responsive, insulin-producing beta cells for future cell-replacement therapy in diabetes. … Read the full press release

University of Leicester health research led by Professor Kamlesh Khunti received £28.4M funding to speed up impact for patients across East Midlands

12-8-2013 — /EuropaWire/ — Research led by University of Leicester health expert aims to speed up impact for patients across the region Issued by Nottinghamshire Heathcare NHS Trust on 9 August 2013 A collaboration between the NHS and universities across the … Read the full press release

Boehringer Ingelheim and Eli Lilly presented clinical trials results evaluating linagliptin efficacy and safety in Asians with Type 2 Diabetes

2-7-2013 — /europawire.eu/ — New Phase III data presented at the American Diabetes Association 73rd Scientific Sessions® (ADA) showed linagliptin improved blood glucose control as monotherapy and in combination with metformin, in Asian people from China, Malaysia and the Philippines with … Read the full press release

Boehringer Ingelheim, Lilly released results of new meta-analysis regarding CV events in linagliptin Phase 3 trials presented at the American Diabetes Association

Ingelheim, Germany and Indianapolis, US, 1-7-2013 — /europawire.eu/ — Boehringer Ingelheim and Eli Lilly and Company today announced results from a new analysis of Phase III data demonstrating that treatment with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is not associated with … Read the full press release

EU Health Prize for Journalists seeks to reward excellence in health journalism, now open to 28 European countries

Brussels, 14-6-2013 — /europawire.eu/ — Today, the virtual doors swing open to journalists from across the EU wishing to participate in the annual EU Health Prize for Journalists. Winners can pick up EU-wide recognition and cash prizes for excellence in health journalism, … Read the full press release

Bayer HealthCare supports Middle East, North Africa and Europe diabetes projects under the “Excellence across Borders” program

Leverkusen, 12-6-2013 — /europawire.eu/ — Bayer HealthCare supports local projects under the “Excellence across Borders” program in order to improve care of people with diabetes. Among the projects is a Diabetic School Awareness Program in the Kingdom of Saudi Arabia, which … Read the full press release